Use of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infections

This publication has 65 references indexed in Scilit:

• Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus
  Antimicrobial Agents and Chemotherapy, 2009
• Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses
  Antimicrobial Agents and Chemotherapy, 2009
• Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model
  Antimicrobial Agents and Chemotherapy, 2009
• Vancomycin MICs for Methicillin-Resistant Staphylococcus aureus Isolates Differ Based upon the Susceptibility Test Method Used
  Antimicrobial Agents and Chemotherapy, 2008
• Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
  Antimicrobial Agents and Chemotherapy, 2008
• Multicenter Evaluation of Vancomycin Dosing: Emphasis on Obesity
  The American Journal of Medicine, 2008
• Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
  Antimicrobial Agents and Chemotherapy, 2008
• Evaluation of Accessory Gene Regulator ( agr ) Group and Function in the Proclivity towards Vancomycin Intermediate Resistance in Staphylococcus aureus
  Antimicrobial Agents and Chemotherapy, 2007
• Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac Surgery
  Antimicrobial Agents and Chemotherapy, 2006
• Prediction of Creatinine Clearance from Serum Creatinine
  Nephron, 1976